Abu-Sbeih H - Search Results

1

Patients with non-colorectal cancers may be at elevated risk of colorectal neoplasia.

Abu-Sbeih H, Ali FS, Qiao W, Lum P, Shafi MA, Bresalier RS, Hawk E, Raju GS, Wang Y. Abu-Sbeih H, et al. J Cancer. 2020 Mar 4;11(11):3192-3198. doi: 10.7150/jca.40724. eCollection 2020. J Cancer. 2020. PMID: 32231724 Free PMC article.

2

Rate of colorectal neoplasia in patients with Hodgkin lymphoma.

Abu-Sbeih H, Ali FS, Tang T, Coronel E, Lee HJ, Pande M, Bresalier RS, Raju GS, Wang Y. Abu-Sbeih H, et al. Colorectal Dis. 2020 Feb;22(2):154-160. doi: 10.1111/codi.14855. Epub 2019 Oct 7. Colorectal Dis. 2020. PMID: 31541529

3

Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis.

Abu-Sbeih H, Ali FS, Luo W, Qiao W, Raju GS, Wang Y. Abu-Sbeih H, et al. J Immunother Cancer. 2018 Sep 25;6(1):95. doi: 10.1186/s40425-018-0411-1. J Immunother Cancer. 2018. PMID: 30253811 Free PMC article.

4

Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor-induced colitis.

Abu-Sbeih H, Ali FS, Wang X, Mallepally N, Chen E, Altan M, Bresalier RS, Charabaty A, Dadu R, Jazaeri A, Lashner B, Wang Y. Abu-Sbeih H, et al. J Immunother Cancer. 2019 Apr 2;7(1):93. doi: 10.1186/s40425-019-0577-1. J Immunother Cancer. 2019. PMID: 30940209 Free PMC article.

5

Patients with breast cancer may be at higher risk of colorectal neoplasia.

Abu-Sbeih H, Ali FS, Ge PS, Barcenas CH, Lum P, Qiao W, Bresalier RS, Bhutani MS, Raju GS, Wang Y. Abu-Sbeih H, et al. Ann Gastroenterol. 2019 Jul-Aug;32(4):400-406. doi: 10.20524/aog.2019.0387. Epub 2019 May 20. Ann Gastroenterol. 2019. PMID: 31263363 Free PMC article.

6

Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson.

Wang Y, Abu-Sbeih H, Mao E, Ali N, Ali FS, Qiao W, Lum P, Raju G, Shuttlesworth G, Stroehlein J, Diab A. Wang Y, et al. J Immunother Cancer. 2018 May 11;6(1):37. doi: 10.1186/s40425-018-0346-6. J Immunother Cancer. 2018. PMID: 29747688 Free PMC article. Review.

7

Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study.

Abu-Sbeih H, Ali FS, Alsaadi D, Jennings J, Luo W, Gong Z, Richards DM, Charabaty A, Wang Y. Abu-Sbeih H, et al. J Immunother Cancer. 2018 Dec 5;6(1):142. doi: 10.1186/s40425-018-0461-4. J Immunother Cancer. 2018. PMID: 30518410 Free PMC article.

8

Safety of endoscopy in cancer patients with thrombocytopenia and neutropenia.

Abu-Sbeih H, Ali FS, Coronel E, Chen HC, Wang X, Lum P, Shuttlesworth G, Bhutani MS, Raju GS, Lee JH, Stroehlein JR, Ross WA, Wang Y. Abu-Sbeih H, et al. Gastrointest Endosc. 2019 May;89(5):937-949.e2. doi: 10.1016/j.gie.2018.12.004. Epub 2018 Dec 11. Gastrointest Endosc. 2019. PMID: 30550744

9

Immune checkpoint inhibitor-induced colitis as a predictor of survival in metastatic melanoma.

Abu-Sbeih H, Ali FS, Qiao W, Lu Y, Patel S, Diab A, Wang Y. Abu-Sbeih H, et al. Cancer Immunol Immunother. 2019 Apr;68(4):553-561. doi: 10.1007/s00262-019-02303-1. Epub 2019 Jan 21. Cancer Immunol Immunother. 2019. PMID: 30666357 Free PMC article.

10

Clinical Review on the Utility of Fecal Microbiota Transplantation in Immunocompromised Patients.

Abu-Sbeih H, Ali FS, Wang Y. Abu-Sbeih H, et al. Curr Gastroenterol Rep. 2019 Feb 28;21(4):8. doi: 10.1007/s11894-019-0677-6. Curr Gastroenterol Rep. 2019. PMID: 30815766 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters